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Background: Fluoroquinolone use has been listed as a risk factor for the emergence of virulent clinical strains of
some bacteria. The aim of our study was to evaluate the effect of fluoroquinolone (gatifloxacin) resistance selection
on differential gene expression, including the toxin genes involved in virulence, in two fluoroquinolone-resistant
strains of Clostridium perfringens by comparison with their wild-type isogenic strains.
Results: DNA microarray analyses were used to compare the gene transcription of two wild types, NCTR and
ATCC 13124, with their gatifloxacin-resistant mutants, NCTRR and 13124R. Transcription of a variety of genes
involved in bacterial metabolism was either higher or lower in the mutants than in the wild types. Some
genes, including genes for toxins and regulatory genes, were upregulated in NCTRR and downregulated in
13124R. Transcription analysis by quantitative real-time PCR (qRT-PCR) confirmed the altered expression of many
of the genes that were affected differently in the fluoroquinolone-resistant mutants and wild types. The levels
of gene expression and enzyme production for the toxins phospholipase C, perfringolysin O, collagenase and
clostripain had decreased in 13124R and increased in NCTRR in comparison with the wild types. After
centrifugation, the cytotoxicity of the supernatants of NCTRR and 13224R cultures for mouse peritoneal
macrophages confirmed the increased cytotoxicity of NCTRR and the decreased cytotoxicity of 13124R in
comparison with the respective wild types. Fluoroquinolone resistance selection also affected cell shape and
colony morphology in both strains.
Conclusion: Our results indicate that gatifloxacin resistance selection was associated with altered gene
expression in two C. perfringens strains and that the effect was strain-specific. This study clearly demonstrates
that bacterial exposure to fluoroquinolones may affect virulence (toxin production) in addition to drug
resistance.
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Clostridium perfringens is commonly found in the gastro-
intestinal (GI) tract of humans, animals, soils, freshwater
sediments and sewage. It can cause various diseases in
humans, including food poisoning, antibiotic-associated
diarrhea, sporadic diarrhea, internal abscesses, and gas gan-
grene and also various animal diseases [1-5]. C. perfringens
strains all are prolific toxin producers and are classified* Correspondence: Fatemeh.Rafii@fda.hhs.gov
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reproduction in any medium, provided the orbased on their toxin formation. Various C. perfringens
toxins denature cellular components of mammalian cells
and are implicated in virulence and pathogenicity. Among
these toxins are α-toxin (phospholipase C, PLC) and
θ-toxin (perfringolysin O, PFO), which are essential for
gas gangrene pathogenesis. Other toxins or hydrolytic
enzymes may be involved in destruction of connective
tissue or spread of bacteria in infected tissues [4,6,7].
C. perfringens, although a commensal, can cause life
threatening infections and is implicated in inflammatory
bowel diseases [8-10]. In a survey of Clostridium species
bacteremia, in a Canadian hospital between 2000–2006,
C. perfringens was shown to have caused 42% of the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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species [11]. It causes nearly a million cases of food
borne illness each year in the United States [1]. Bac-
teria from the GI tract, including C. perfringens, may
become resistant to fluoroquinolones used for treat-
ment or prophylaxis of bacterial infections. Surveys of
fluoroquinolone-resistant-anaerobes found ciprofloxacin-
resistant C. perfringens as early as 1992 among clinical
isolates [12]. Although similar surveys have not been
conducted in recent years, Gionchetti et al. [10] showed
that treatment of patients with chronic treatment-
resistant pouchitis with 1 g of ciprofloxacin for 15 days
did not result in a statistically significant reduction in
C. perfringens. One reason for fluoroquinolone resist-
ance development is mutation in the fluoroquinolone
target genes, gyrase (gyrA and gyrB) and topoisomerase
IV (parC and parE) [13]. Because fluoroquinolones are
DNA-damaging agents, they may also induce the SOS
response [14-16] that results in expression of DNA re-
pair genes, which may lead to phenotypic changes in
fluoroquinolone-resistant strains [17-20]. Excessive use
of fluoroquinolones has been attributed to the emergence
of virulent strains of bacteria [21-24]. Clostridium difficile
strain NAP1/027, which emerged in 2002 in Canada
and the USA, now has spread to most parts of Europe
[22]. In a gut model, higher rates of spore germination
and levels of toxin production were observed in two
ribotypes of C. difficile that were exposed to three dif-
ferent fluoroquinolones [24]. Wide dissemination of
virulent fluoroquinolone-resistant strains of Escherichia
coli has been reported in East Asia [25]. Other reports,
sometimes conflicting, show either increased or de-
creased virulence in fluoroquinolone-resistant clinical
isolates of bacteria [26-28]. Previously we showed that
different C. perfringens strains rapidly developed resist-
ance, even to high potency fluoroquinolones, and that
resistant strains had various mutations in the fluoro-
quinolone target genes [29]. In addition, the production
of some enzymes was altered in some resistant mutants
[30,31]. One gatifloxacin-resistant strain, NCTR, had
increased levels of α-toxin (phospholipase C, PLC) and
θ-toxin (perfringolysin O, PFO) [30]. These results
point to global changes in the expression of various
genes in gatifloxacin- resistant strains and to the need
for further study. In this study, we have used genomic
analysis (microarray and QRT-PCR) to compare the
changes in gene expression in two gatifloxacin-resistant
strains of C. perfringens following fluoroquinolone re-
sistance selection, and have compared the toxin pro-
duction and cytotoxicity of the strains. Strain NCTR
was selected because of enhanced production of PLC
and PFO by its gatifloxacin resistant mutant and was
compared with strain ATCC 13124, which is a gangrene
isolate whose genomic sequence is known, and itsgatifloxacin resistant mutant 13124R has the same
mutation in gyrA as NCTRR.Methods
Growth of bacterial strains
Wild types and gatifloxacin-resistant mutants of C.
perfringens strains ATCC 13124 and NCTR [29] were
used in this study. The development of these mutants
(Gat-13124-10 and Gat-NCTR- 10) was described previ-
ously [29]. Both mutants have stable mutations in target
genes and will be referred to as 13124R and NCTRR in
this study. Both mutants had a mutation in gyrA (G81C,
D87Y), 13124R had mutation in gyrB (A431S) and parC
(S89I), and NCTRR had a mutation in parE (E486K).
The bacteria were grown anaerobically under an atmos-
phere of 85% N2, 10% CO2, and 5% H2 at 37°C in brain
heart infusion (BHI) broth (Remel, Lenexa, KS) with
vitamin K (1 μg/ml), hemin (5 μg/ml), and L-cysteine
(5 μg/ml) (Sigma Chemical Co., St. Louis, MO) [29]. No
antibiotics were added.Preparation of RNA
Early exponential (2.5-3.0 h) growth phase cultures of all
four strains, grown in BHI under identical anaerobic
conditions, were used to isolate RNA for microarrays.
Cells from 100-ml cultures were harvested by centrifuga-
tion (15,000 × g, 10 min, 4°C), washed with 10 mM Tris
and 1 mM EDTA (pH 8.0), and suspended in 1 ml of
buffer containing 10 mg/ml of lysozyme (Sigma). The mix-
tures were incubated for 10 min at room temperature and
centrifuged (15,000 × g, 10 min, 4°C). The samples were
suspended in 0.5 ml TE (10 mM Tris, 1 mM EDTA)
and mixed with 5 ml of RNA-Bee isolation reagent
from TEL-TEST, Inc. (Friendship, TX). After addition
of 1 ml chloroform to the mixture, the samples were in-
cubated on ice for 30 min and centrifuged (15,000 × g,
30 min, 4°C). The clear phases were harvested, added
to an equal volume of isopropanol and centrifuged to
pellet the RNA. The RNA was further purified using an
RNeasyR Mini Kit (50) from QIAGEN, Inc. (Valencia,
CA), according to the instructions provided with the
kit. After RNA extraction and purification, contaminat-
ing DNA was removed using 10 U of RNase-free DNase
1 (Boehringer Mannheim, Ingelheim, Germany). The
quantity and quality of total RNA was determined using
a Nanodrop ND-1000 spectrophotometer (NanoDrop
Technology, Wilmington, DE). RNA purification steps
for real-time PCR (qRT- PCR) were essentially the same.
The RNA was stored at −80°C and used within a week to
avoid degradation of RNA. RNA was extracted from three
different cultures of each strain for microarray analysis
and qRT-PCR.
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The probes were designed by Biodiscovery LLC, Ann Arbor,
MI (http://www.mycroarray.com/) from the sequences
of C. perfringens strains 13 (CPE) and ATCC 13124
(CPF in http://www.ncbi.nlm.nih.gov), using OligoArray v
3.1 (http://berry.engin.umich.edu). The designs of micro-
arrays were submitted to MIAMExpress and can be
accessed at the following links: for strain 13124, [http://
www.ebi.ac.uk/arrayexpress/arrays/A-MEXP-2008], and for
strain NCTR, at [http://www.ebi.ac.uk/arrayexpress/arrays/
A-MEXP-2027].
Microarray hybridization
The microarrays were hybridized by Biodiscovery LLC
to fluor-labeled RNA at 60°C for at least 16 h in 2-
gasket slides and commercial hybridization chambers
(Agilent, Santa Clara, CA) while being rotated (~4 rpm)
in a hybridization incubator. The hybridization solution
contained 6 × SSPE (1 M NaCl, 50 mM NaH2PO4,
50 mM Na2HPO4, 3 mM EDTA, pH 6.7), 1 μg/μl acety-
lated BSA, 1 μg/μl herring sperm DNA (Promega,
Madison,WI), 0.01% Tween 20 (Sigma) and 10 μg tem-
plate RNA per array. The hybridized arrays were
washed twice in 6 × SSPE for 5 min at 60°C, once in 1 ×
SSPE for 5 min at 20°C, and once in 0.25 × SSPE at 20°C
for 1 min, and then were spun dry in a microarray high-
speed centrifuge (ArrayIT, model MHC). The arrays were
scanned in an Axon 4000B scanner (Molecular Devices
Sunnyvale, California), controlled by GenePixPro software
(v 6.1.0.4). The resulting images were quantified with
the same software and the results were archived in the
gpr file format. The mean expression of each gene for
the mutant was divided by the mean expression of the
same gene for the wild type. Those genes for which
the values were ≥ 1.5 were considered upregulated in
the mutant, and the genes for which this value was
≤0.6 were considered downregulated in the mutant.
The genes that were upregulated or downregulated
were selected for further RT-PCR analysis.
Quantitative real-time PCR (qRT-PCR)
Primers used for qRT-PCR are listed in Additional file 1.
The genes that were upregulated in one mutant and
downregulated in the other mutant, in comparison with
their respective wild types, by microarray analysis were
selected to design primers. Some genes involved in regu-
lation of transcription were also selected. The sequence
of C. perfringens ATCC 13124 (http://www.ncbi.nlm.nih.
gov/nuccore/CP000246.1) was used to design primers
that generated PCR amplicons of 100–150 bp in length
via the default setting of “Primer 3 Input software”
(http://frodo.wi.mit.edu/primer3). For cDNA template
synthesis, SuperScriptTM III First-Strand Synthesis
SuperMix (Invitrogen, Carlsbad, CA) was used. ForqRT-PCR, SYBRW GreenERTM qPCR SuperMix (Invitrogen)
was used. The reaction mixtures were prepared on ice
according to the manufacturer’s instructions. Each reac-
tion contained 2 × Express SYBR Green ER qRT-PCR
universal mix, 25, 2.5, or 0.25 ng of the cDNA template,
and 2 μM each of the forward and reverse primers. The
amplification was performed using a CFX96 Real-Time
PCR detection system (Bio-Rad, Hercules, CA) and the
following protocol: 50°C for 10 min, 95°C for 8.5 min
to inactivate uracil DNA glycosylase and activate DNA
polymerase, followed by 40 cycles of 95°C for 15 s and
60°C for 1 min to amplify cDNA. Melting curves were
monitored at 65-95°C (1°C per 5 s) to detect any
nonspecific amplification. Either 25, 2.5, or 0.25 ng of
each 16S rRNA gene was amplified as a reference
RNA of equivalent size for normalization [32]. Reaction
mixtures without reverse transcriptase, for detecting
genomic DNA contamination, and reaction mixtures
without templates, for detecting nucleic acid contamin-
ation of reagents and tubes, were included as controls.
Each PCR reaction was run in triplicate for each type
of RNA isolated from three different cultures of each
wild type or mutant. The relative level of mRNA expres-
sion was calculated by the 2-ΔΔCT method according to
Real-Time PCR Application Guide (Additional file 2).Detection of phospholipase C (PLC) and perfringolysin
O (PFO)
PLC and PFO activities were measured according to the
methods previously described [7,30,33]. The hemoglobin re-
lease from red blood cells in the presence of perfringolysin
buffer was measured to detect perfringolysin O (PFO)
according to the method of O'Brien and Melville [33]. The
increase in turbidity of lecithin in egg yolk emulsion or the
release of nitrophenol from O-(4-nitrophenyl-phosphoryl)
choline as the result of hydrolysis by PLC was used to
measure phospholipase C (PLC) activity [7,30].Collagenase assay
The amounts of collagenase in the mutants and wild
types were calculated by the method of Awad et al. [34]
by measuring the amount of dye released from Azo Dye
Impregnated Collagen (azocoll) (Sigma). Azocoll powder
was washed and resuspended in 0.2 M of borate buffer
(pH 7.2) containing 0.15 M NaCl, 20 μM ZnCl2 and
5 mM CaCl2 to a final concentration of 5 mg azocoll
per ml. Next, 100 μl of the filter-sterilized supernatants
of centrifuged wild types and mutants were added to
400 μl of azocoll solution and the mixtures were incu-
bated for 2 h at 37°C. Following centrifugation at
16,100 × g, the released dye was measured by the ab-
sorbance at 550 nm.
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A clostripain substrate, N-carbobenzoxy-L-arginine p-
nitroanilide (Z-Arg-pNA) (Bachem Americas, Torrance,
CA), was used for measuring the amounts of clostripain
in the supernatants of wild types and mutants [35]. The
filter-sterilized supernatant from each centrifuged strain
was incubated overnight at 4°C in a buffer containing
dithiothreitol to reduce the thiol group of the cysteine
residues of clostripain. Next, 20 μl of the sample was
added to the 300 μl buffer containing 2 mM CaCl2 and
260 mM of Z-Arg-pNA. The kinetics software of the
spectrophotometer was programmed to measure the
absorbance at 410 nm every min for 30 min. The amount of
cleavage of Z-Arg-pNA was measured and the enzyme units
were calculated. One unit was defined as the amount of en-
zyme that hydrolyzed 1.0 μmol of Z-Arg-pNA per min [35].
Detection of sialidase
Sialidase activity was measured in filter-sterilized superna-
tants of centrifuged cultures of mutants and wild types, using
4 mM 5-bromo-4-chloro-3-indolyl-α-D-N-acetylneuraminic
acid, sodium salt [36]. The assay reaction was performed
in 96-well plates by addition of the supernatant to wells
containing the substrates, according to a procedure
recommended by Sigma for measuring recombinant C.
perfringens neuraminidase. The kinetics software was pro-
grammed to measure the absorbance at 595 nm.
Hyaluronidase detection
The amounts of hyaluronidase in the filter-sterilized su-
pernatants of centfifuged wild types and mutants were
quantified by measuring the degradation of hyaluronic
acid. Bovine hyaluronic acid (Sigma) was dissolved in
acetate buffer (200 mM sodium acetate, 150 mM NaCl,
pH 6.0) to a final concentration of 1 mg/ml. 100 μl of
the hyaluronic acid solution was incubated with 400 μl
of the filter-sterilized supernatants of the wild types and mu-
tants for 30 min at 37°C. One ml of a solution containing
2% NaOH and 2.5% cetramide (cetyltrimethylammonium
bromide, Sigma) was added to the reaction mixture. The
turbidity of the insoluble complex formed between
cetramide and hyaluronic acid was measured at 400 nm
[37]. The reduction in turbidity, reflecting the decrease in
hyaluronic acid because of the activity of hyaluronidase,
was calculated by comparing the turbidities of samples
containing the supernatant of each culture with controls
containing BHI alone. The enzyme assays for all the en-
zymes were performed three times from three different
cultures of each strains.
Cytotoxicity of C. perfringens supernatants for
macrophages
Macrophages were obtained from C57BL/6 male mice,
4–6 weeks old, which had ad libitum access to food andwater. The maintenance, handling and sacrifice of mice
were according to procedures approved by the NCTR
Institutional Animal Care and Use Committee. Resident
mouse peritoneal macrophages were harvested by peri-
toneal lavage, using 4 ml of supplemented DMEM
medium, containing 5% heat-inactivated fetal bovine
serum, 100 μg/ml streptomycin sulfate, 100 units/ml
penicillin G, 110 mg/L sodium pyruvate, and 2 mM
glutamine. Red blood cells were removed by hypotonic
lysis. The peritoneal exudate cells were washed once
with DMEM, plated and incubated at 37°C in a humidi-
fied atmosphere of 5% CO2 [33]. Floating cells were re-
moved and the macrophages were incubated in DMEM,
containing 10% BHI or filter-sterilized supernatants of
overnight cultures of wild types and mutants, for
18 h at 37°C in a CO2 incubator. A CytoTox 96
W
Non-Radioactive Cytotoxicity Assay Kit (Promega) was
used to measure the toxicity of the mutants and wild type
cultures for macrophages. The cytotoxicity of each
absorbance unit of the cells of different strains was
calculated by the amount of lactate dehydrogenase (LDH)
released from the macrophages. The differences in cyto-
toxicity due to the mutants and wild types were assessed
using Student’s t-test.
Morphological examination
Colony morphology of the strains was compared after
overnight growth on BHI plates. For cellular morph-
ology, log phase grown cells were Gram stained and ex-
amined under the light microscope.
DNA sequencing
Several regulatory and toxin genes and enzymes from
wild types and mutants were amplified and sequenced as
previously described [29].
Results
Transcriptional analysis by DNA microarray
Using the genome sequences of C. perfringens strain
13 and strain ATCC 13124, microarray probes were
designed for genome-wide transcriptional analysis of
two fluoroquinolone-resistant C. perfringens strains, NCTRR
and 13124R, and their wild types. Microarray analysis
showed that a variety of genes were upregulated (≥ 1.5
fold) or downregulated (≤ 1.5 fold) in the fluoroquinolone-
resistant strains. The altered genes with known functions
that were affected in both strains as the results of fluoro-
quinolone resistance selection are grouped in Tables 1, 2, 3
according to the classification used by the Institute for
Genomic Research (http://www.jcvi.org/). In addition, the
microarray detected alterations of many genes, for which
the function is not known, which are listed as hypothetical
proteins in the GenBank. Some of these were upregulated
manyfold in both resistant strains, especially in 13124R.
Table 1 Microarray and qRT-PCR analysis of the genes that were differentially affected in the gatifloxacin resistant
mutants, NCTRR and 13124R
Gene ID and name Function Microarray qRT-PCR
mt/wt mt/wt
NCTR ATCC 13124 NCTR ATCC 13124
Cell envelope
CPE1089 CPF_1345 putative membrane protein 4.3 −2.1 7.3 −2.8
CPE0162 CPF_0155 (pfoR) putative membrane protein 2.6 −4.0 3.3 −3.5
CPE0251 CPF_0244 putative lipoprotein 5.0 −2.4 2.0 −3.5
CPE0278 CPF_0274 (sagA) sagA protein 1.1 −2.4 4.7 −2.6
CPE0714 CPF_0710 putative monogalactosyl-diacylglycerol synthase 2.4 −2.4 7.6 6.3
Cellular processes
CPE0036 CPF_0042 (plc) phospholipase C 4.8 −6.8 1.9 −3.3
CPE0846 CPF_0840 (cloS1) α-clostripain 17.3 −15.6 8.3 −1143
CPE1474 CPF_1725 (hlyC) hemolysin III 3.2 −1.8 15.1 −2.6
CPE0163 CPF_0156 (pfoA) perfringolysin O 3.6 −71.4 6.4 −462
CPE0782 CPF_0784 (ahpC) alkyl hydroperoxide reductase-C subunit 10.3 −2.6 13.4 −12.6
CPE1092 CPF_1348 (pac) choloylglycine hydrolase family protein 1.7 −2.5 25.7 −1.7
Energy metabolism
CPE0778 CPF_0780 oxidoreductase, FDA-binding 4.8 −2.8 85 2.6
CPE1299 CPF_1505 (eno) enolase 3.5 −1.6 11.9 −1.9
CPE2058 CPF_2315 (gadB) glutamate decarboxylase 31.9 −3.5 20.0 −3.4
CPE2437 CPF_2747 (nrdH) glutaredoxin-like protein, YruB-family 3.8 −2.5 4.8 −11.0
CPE2551 CPF_2875 (glpA) probable glycerol-3-phosphate dehydrogenase 0.8 −2.5 1.3 −0.1
Purines, pyrimidines, nucleotides, and nucleosides
CPE2276 CPF_2558 (guaB) inosine-5’-monophosphate dehydrogenase 9.2 −3.6 30.3 −1.5
CPE2622 CPF_2958 (purA) adenylosuccinate synthetase 4.3 −1.9 14.8 −0.8
Protein fate
CPE0173 CPF_0166 (colA) collagenase 9.9 −4.7 8.5 −2.7
CPE2323 CPF_2632 (pepF) probable oligoendopeptidase F 2.7 -2.0 11.6 4.3
CPE1205 CPF_1002 (abgB) amidohydrolase family protein 1.9 −4.3 67.4 −1.6
Regulatory functions
CPE0073 CPF_0069 transcription antiterminator 2.1 −5.0 1.9 −2.6
CPE0759 CPF_0753 putative regulatory protein 1.5 −5.4 3.3 0.6
CPE1533 CPF_1784 (scrR) sucrose operon repressor 1.7 −2.8 132 −1.5
CPE2035 CPF_2292 (hrcA) heat-inducible transcription repressor HrcA 2.3 −2.9 9.5 5.5
CPE2363 CPF_2673 two-component sensor histidine kinase 2.1 −3.0 16.1 2.7
Transport and binding proteins
CPE1240 CPF_1450 (mgtE) magnesium transporter 8.6 −1.7 5.2 −2.6
CPE1300 CPF_1507 (gadC) glutamate:γ-aminobutyrate antiporter family protein 9.6 −2.7 17.1 −7.3
CPE1505 CPF_1756 (uraA) uracil transporter 3.8 −2.7 3.9 −4.6
CPE0075 CPF_0070 N-acetyl glucosamine-specific 1.4 −14.3 1 .8 ND
CPE0707 CPF_0703 ABC transporter, ATP-binding protein 1.5 −3.2 5.2 2.9
CPE0761 CPF_0756 (gltP) proton/sodium-glutamate symporter 1.5 −4.2 4.6 0.9
CPE1371 CPF_1621 sodium:neurotransmitter symporter family protein 1.8 −4.0 15.2 2.7
CPE2084 CPF_2341 (modB) molybdate ABC transporter, permease protein 1.8 −2.5 10.8 2.0
CPE2343 CPF_2652 (malE) putative maltose/maltodextrin ABC transporter 2.9 1.3 3.8 −2.1
Unknown functions
CPE0183 CPF_0176 nitroreductase family protein 1.0 −4.8 2.9 −1.1
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Table 1 Microarray and qRT-PCR analysis of the genes that were differentially affected in the gatifloxacin resistant
mutants, NCTRR and 13124R (Continued)
CPE1172 CPF_1375 haloacid dehalogenase 2.1 −2.4 20.6 −1.7
CPE1784 CPF_2038 (nifU) NifU family protein 1.3 −2.5 6.4 −1.5
CPE2448 CPF_2758 PSP1 domain-containing protein 1.0 −2.4 5.5 −1.9
All of the data are the means of three different experiments.
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strains are shown in Table 1. Many of these genes were
generally upregulated in NCTRR and downregulated in
13124R. The common genes that were upregulated in one
or both mutants are in Table 2 and those that were
downregulated in both are in Table 3. Some genes involved
in amino acid biosynthesis, protein synthesis, fatty acid
synthesis, and phospholipid metabolism were mostly
upregulated in 13124R. Some genes for putative mem-
brane proteins were upregulated in either one (Table 1)
or both mutants (Table 2). The ATP synthase and potas-
sium transporter genes were upregulated in both mutants
(Table 2). Some of the genes involved in purine, pyrimi-
dine, nucleotide, and nucleoside transport and metabolism
were upregulated in both mutants and some were
downregulated in both mutants (Tables 2 and 3). Sev-
eral transcriptional regulators, transporters and kinases
also were downregulated in one or both mutants
(Tables 1 and 3). Resistance selection also affected the
expression of genes involved in virulence (phospholip-
ase C, perfringolysin O, collagenase, hemolysin III and
α-clostripain). Surprisingly, these genes were upregulated
in strain NCTRR and downregulated in strain 13124R.
Validation of DNA microarray data by qRT-PCR
To verify that fluoroquinolone resistance selection in-
deed had different effects on the expression of some of
the genes in C. perfringens, the transcription of the genes
that were generally upregulated or unchanged in NCTRR
and downregulated in 13124R was measured by qRT-
PCR (Table 1). Real-time PCR verified the upregulation
of all of the genes that were tested in NCTRR and
downregulation of a majority of the genes that were
downregulated in 13124R. qRT-PCR was also performed
on the genes that are reported to have regulatory
functions (Table 4). virR, virS, vrr, virX and others were
all upregulated in NCTRR by at least twofold. In strain
13124R, virX was downregulated more than twofold,
but vrr also was substantially downregulated. Among
the genes whose expression was altered by fluoroquino-
lone resistance selection were phospholipase C (PLC),
perfringolysin O (PFO), α-clostripain, hemolysin III,
and collagenase. Both microarray analysis and qRT-PCR
showed upregulation of these genes in NCTRR and
downregulation in 13124R. Both microarray and qRT-PCRshowed downregulation of the sialidase gene, nanI, in
NCTRR and upregulation of this gene in 13124R.
Toxin production in the mutants and wild types
The quantities of several enzymes that are implicated in
bacterial virulence were measured for each absorbance
unit of cells of wild types and mutants of both strains
(Figures 1 and 2). The production of phospholipase C
(PLC), perfringolysin O (PFO), collagenase, clostripain,
and sialidase were all affected in the resistant mutant.
Strain 13124R produced less PLC and PFO than the wild
type. In contrast, as previously reported [30], the pro-
duction of both enzymes increased in NCTRR. Collage-
nase and clostripain production also were similarly
affected by fluoroquinolone resistance selection, but the
most dramatic effect was for perfringolysin O (PFO) in
ATCC 13214, which was totally inhibited in 13124R.
However, sialidase had increased in 13124R but de-
creased in NCTRR. Hyaluronidase was not significantly
affected. The alterations in the production of PLC, PFO,
collagenase and clostripain in both strains reflected the
alteration of gene expression for these enzymes, as
shown by microarray and qRT-PCR.
Cytotoxic effects on mouse peritoneal macrophages
To investigate if the changes in the expression levels
of toxin genes in the fluoroquinolone resistant mu-
tants affected cytotoxicity for phagocytes, cytotoxi-
city assays were performed by incubating mouse
peritoneal macrophages with cell-free filtrates of the
centrifuged bacterial cultures. The levels of cytotoxicity
were compared by measuring the amount of lactate de-
hydrogenase (LDH) released from the lysed macrophages.
The relative cytotoxicity was about threefold lower (P=
0.0131) in 13124R than in ATCC 13124 (Figure 3). The
supernatant of NCTRR showed about 1.4-fold higher cyto-
toxicity than that of NCTR. Microscopic observation also
indicated that macrophages treated with bacterial culture
media from ATCC 13124 and NCTRR were rounded off
and detached from the surface (Additional file 3).
Morphological examination
Gram staining of log phase cultures showed that gatif-
loxacin resistance selection affected the shape of cells (Add-
itional file 4). As expected, the Gram reaction was positive
Table 2 Microarray analysis of the genes that were upregulated in one or both gatifloxacin-resistant mutants, 13124R
and NCTRR
Gene ID and name Function/Similarity Microarray (mt/wt)
NCTR ATCC 13124
Amino acid biosynthesis
CPE1520 CPF_1772 (ilvE) branched-chain amino acid aminotransferase 1.1 2.6
CPE1905 CPF_2161 (dapA) dihydrodipicolinate synthase 1.0 1.9
Cell envelope
CPE0492 CPF_0465 capsular polysaccharide biosynthesis protein 6.5 1.9
CPE0495 CPF_0468 UDP-glucose/GDP-mannose dehydrogenase family 3.5 2.4
CPE2059 CPF_2316 putative membrane protein 7.1 3.2
CPE2079 CPF_2336 putative membrane protein 14.2 2.1
CPE0785 CPF_0787 putative membrane protein 2.3 2.1
Energy metabolism
CPE2186 CPF_2451 (atpE) ATP synthase epsilon subunit 3.3 2.9
CPE2187 CPF_2452 (atpB) ATP synthase beta subunit 3.6 2.2
CPE2189 CPF_2454 (atpA) ATP synthase alpha subunit 4.2 2.4
CPE2190 CPF_2455 (atpH) ATP synthase delta subunit 1.9 2.1
CPE2191 CPF_2456 (atpF) ATP synthase B chain 2.2 2.3
CPE2192 CPF_2457 (atpL) ATP synthase C chain 3.6 2.3
Fatty acid and phospholipid metabolism
CPE1068 CPF_1324 (fabH) 3-oxoacyl-(acyl-carrier-protein) synthase III 2.2 4.7
CPE1069 CPF_1325 (fabD) malonyl CoA-acyl carrier protein transacylase 1.1 3.6
CPE1071 CPF_1327 (fabF) 3-oxoacyl-(acyl-carrier-protein) synthase II 1.3 3.8
CPE1072 CPF_1328 (accB) acetyl-CoA carboxylase, biotin carboxyl carrier 0.9 4.0
CPE1073 CPF_1329 (fabZ) beta-hydroxyacyl-(acyl-carrier-protein) dehydratase FabZ 1.0 4.5
CPE1074 CPF_1330 (accC) acetyl-CoA carboxylase, biotin carboxylase 1.7 4.9
CPE1075 CPF_1331 (accD) acetyl-CoA carboxylase, carboxyl transferase, beta subunit 3.4 5.0
CPE1076 CPF_1332 (accA) acetyl-CoA carboxylase, carboxyl transferase, alpha subunit 1.9 4.6
Protein synthesis
CPE1697 CPF_1951 (frr) ribosome recycling factor 1.1 2.0
CPE2441 CPF_2720 ribosomal protein L7AE family 1.1 2.6
CPE2660 CPF_2997 (rpmH) ribosomal protein L34 1.4 2.0
Purine, pyrimidine, nucleotides, and nucleosides
CPE1050 CPF_1305 (mtnH) 5-methylthioadenosine/S-adenosylhomocysteine nuclosidase 3.2 2.6
CPE2162 CPF_2418 (cpdC) 2`,3`-cyclic-nucleotide 2`-phosphodiesterase 3.4 1.6
Transport and binding proteins
CPE0977 CPF_1235 potassium transporter 7.1 2.9
Unknown functions
CPE2601 CPF_2928 conserved hypothetical protein 6.7 58.0
All of the data are the means of three different experiments.
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tants were more elongated than the wild types but the
amounts of elongation and differences in cell shape
were much more pronounced for the NCTR/NCTRR
strain pair than for the ATCC 13214/13124R strain pair.
Fluoroquinolone resistance selection also affected the col-
ony morphology of the resistant strains. The colony size of
NCTRR was bigger than that of the wild type, and thecolony size of 13124R was smaller than that of the wild
type (Additional file 4).
Discussion
The use of fluoroquinolones has been listed as a risk fac-
tor for the emergence of virulent antibiotic-resistant
strains of some bacteria [21-23]. We studied the effect
of fluoroquinolone resistance selection on the global
Table 3 Microarray analysis of the genes that were downregulated in both gatifloxacin-resistant strains, 13124R
and NCTRR
Gene ID (name) Function/Similarity Microarray (mt/wt)
NCTR ATCC 13124
Biosynthesis of cofactors, prosthetic groups, and carriers
CPE1085 CPF_1341 (ispH) 4-hydroxy-3-methylbut-2-enyl diphosphate reductase −2.4 −2.2
Energy metabolism
CPE0292 CPF_0288 carbohydrate kinase family protein −3.1 −2.5
CPE1185 CPF_1389 (pfk) 6-phosphofructokinase −1.7 −2.7
CPE0585 CPF_0565 (fruB) fructose-1-phosphate kinase −5.2 −2.3
CPE0692 CPF_0684 transaldolase −2.8 −2.3
CPE0725 CPF_0721 (nanI) * exo-alpha-sialidase −3.5 1.5
CPE0894 CPF_0887 (eutP) ethanolamine utilization protein, EutP −1.9 −2.0
CPE2348 CPF_2657 (ptb) phosphate butyryltransferase −2.3 −1.6
Purine, pyrimidine, nucleotides, and nucleosides
CPE1398 CPF_1652 (deoD) purine nucleoside phosphorylase −1.7 −3.4
Regulatory functions
CPE0586 CPF_0566 (fruR) transcriptional regulator, DeoR family −3.6 −2.6
CPE0631 CPF_0612 probable PBP5 synthesis regulator protein −2 −2.5
CPE1077 CPF_1333 transcriptional regulator, PadR family −3.1 −3.2
CPE2510 CPF_2833 transcriptional regulator, PadR family −2.6 −2.7
CPE1305 CPF_1512 probable transcriptional regulator −2 −1.6
Transport and binding proteins
CPE0600 CPF_0581 amino acid ABC transporter −4.8 −3.4
CPE1534 CPF_1785 PTS system, sucrose-specific IIBC component −3.1 −14.3
CPE2345 CPF_2654 putative maltose/maltodextrin ABC transporter −2.0 −1.8
Unknown functions
CPE2509 CPF_2832 degV family protein −3.6 −3.3
CPE1171 CPF_1374 mutator mutT protein homolog −6.4 −2.0
CPE2592 CPF_2917 phnA family protein −2. 8 −2.0
* Decrease in the expression of nanI in NCTRR and increase of its expression in 13124R was confirmed by qRT-PCR.
All of the data are the means of three different experiments.
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perfringens strains 13124R and NCTRR by microarray ana-
lysis. The fluoroquinolone resistance selection resulted in
alteration of transcription levels of a significant number of
genes involved in almost every aspect of metabolism in
the resistant mutants of both strains in comparison withTable 4 Results of qRT-PCR for the C. perfringens regulatory g
Gene ID and name Regulat
CPE_1501 CPF_1752 (virR) DNA binding response re
CPE_1500 CPF_1751 (virS) sensor histidine kinase, V
CPE_0646 CPF_0627 (virX) conserved hypothetical p
CPE_0957 CPF_1204 (vrr) VR-RNA
CPE_1701 CPF_1955 (codY) GTP-sensing transcription
CPE_0073 CPF_0069 Transcription antitermina
CPE_0642 CPF_0623 (RevR) DNA binding response retheir wild types. Many genes with similar functions were ei-
ther upregulated or downregulated in the resistant mutants.
However, some genes that were downregulated in 13124R
were upregulated in NCTRR. qRT-PCR analysis confirmed
that the transcription of these genes, which included toxin
genes for phospholipase C (PLC), perfringolysin O (PFO),enes in the wild types and mutants
ory function qRT-PCR fold
change (mt/wt)
NCTR ATCC13124
































































Figure 1 Comparison of phospholipase C (A) and perfringolysin O (B) activities of the wild type strains of C. perfringens, ATCC 13124
and NCTR, with their respective mutants, 13124R and NCTRR. W: wild type, M: mutant.
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http://www.biomedcentral.com/1471-2180/13/50collagenase and clostripain, were affected differently in the
two mutants. Similarly, the production of these enzymes
and the toxicity of the culture supernatants decreased in
13124R and increased in NCTRR. It appears that gati-
floxacin resistance selection resulted in alteration of global
gene transcription in C. perfringens and that the effect was
strain-specific.
The changes in the levels of global gene expression due
to the response to fluoroquinolone exposure may be
governed by complex regulatory processes. Both resistant
strains harbored some common and some unique muta-
tions in fluoroquinolone target genes. These enzymes are
involved in the DNA supercoiling process that plays an es-
sential role during gene transcription [38,39]. Although
neither of the resistant strains was a clinical isolate, some
of the mutations found in the resistant strains were the
same as those found in fluoroquinolone-resistant mutants
of E. coli obtained from clinical samples, which were also
the same as those found in fluoroquinolone-resistant mu-
tants of E. coli generated in the laboratory [29,40].
The expression of a number of genes is affected by
supercoiling [19] and aberrant expression of these genes
occurs when DNA supercoiling has been altered by gyrasemutation(s). Alleles of gyrA that reduce DNA supercoiling
have been shown to generate metabolic defects and re-
duce fitness of gyrase mutant strains [38,41]. Furthermore,
because fluoroquinolones are DNA-damaging agents, in
addition to inducing mutation in target genes, changing
DNA superhelicity, they may also induce the expression
of DNA repair genes via the SOS response, which may
lead to phenotypic changes [15,17-20]. Cirz et al. [15]
characterized the global transcription response of S.
aureus to ciprofloxacin and, among other changes, found
induction of the SOS response, upregulation of the TCA
cycle and downregulation of α-hemolysin and a leukocidin
family toxin. The positive regulators of transcriptional re-
sponses for stress and toxin genes were also downregulated
[15]. In C. perfringens, although the expression of several
virulence genes decreased in one resistant mutant (13124R),
it increased in another (NCTRR). The transcription of vari-
ous genes, including toxin genes, is regulated by virR and
virS [32,42,43]. VirS is a sensor histidine kinase, which au-
tophosphorylates in response to extracellular signals, and
VirR is a response regulator [32,42,43]. These two genes,
along with vrr (which is an RNA regulator virR-RNA), are
















Figure 3 Comparison of cytotoxicity of two gatifloxacin-
resistant C. perfringens mutant strains, 13124R and NCTRR, with
their wild type parents, strains ATCC 13124 and NCTR, for






















































































Figure 2 Comparison of collagenase (A), clostripain (B) and
sialidase (C) activities of the wild type strains of C. perfringens,
ATCC 13124 and NCTR, with their respective mutants, 13124R
and NCTRR. W: wild type, M: mutant.
Park et al. BMC Microbiology 2013, 13:50 Page 10 of 13
http://www.biomedcentral.com/1471-2180/13/50upregulated in NCTRR. In 13124R, transcription of VirR
did not change, and virS and vrr were downregulated. The
gene vrr is directly regulated by VirR/VirS, and as a regula-
tory RNA, controls transcription of 147 genes, including
housekeeping and toxin genes, in C. perfringens [32,44].
Obana et al. [45] showed that VR-RNA regulates the stabil-
ity of colA mRNA by cleaving the transcript. The processed
shorter colA transcript was more stable than the longer in-
tact colA transcript. It is possible that among other fac-
tors, downregulation of vrr in 13124R (−158) may havecontributed to a decrease in the level of transcription of
genes. The vrr in NCTRR was upregulated twofold. virX is
another regulatory gene that, even in the absence of the
VirR/VirS regulatory system, activates the transcription of
the pfoA, plc and colA genes, and its overexpression results
in the increased expression of toxin genes [44,46]. qRT-
PCR results showed that the expression of this gene in-
creased at least 2.2 times in NCTRR and decreased by −3.0
in 13124R.
Another regulatory gene whose expression was altered
in the mutants was revR, which was downregulated in
13124R and upregulated in NCTRR. revR is a response
regulator that alters the transcription of 100 genes,
including those for potential virulence factors, which
also are regulated by (VirR/VirS), and those for cell wall
metabolism [47]. Hiscox et al. [47] found that a revR
mutant of C. perfringens 13 was filamented. Gram stain-
ing of the wild types and mutants of ATCC 13124 and
NCTR showed that cells of both mutants were
filamented and longer than those of the wild types.
Microarray and qRT-PCR analysis (Table 1) showed that
some putative membrane protein genes were differen-
tially expressed in the mutants and wild types of both
strains.
The amino acid sequences of the toxin genes and the
regulatory genes (virR/virS) in the mutants and wild
types of both strains were identical, except that there
were two silent mutations in virR/virS in NCTRR, so the
expression of toxin genes and their regulators was not
the result of gene mutation. The sequence of vrr was
identical in the mutants and wild types of both strains,
and the sequence of revR in ATCC 13124 and 13124R
was also identical. Obana and Nakamura [48] also
detected other regulatory genes, CPE_1446-CPE_1447,
which appear to regulate the transcription of plc, pfoA,
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lysis showed that CPE_1447 was downregulated in NCTRR,
but this gene was not detected in the microarray data
from ATCC 13124. qRT-PCR confirmed that nanI was
downregulated and sialidase was decreased in NCTRR;
however, the role of CPE_1447 in the regulation of this
gene is not clear.
Another global regulatory protein, CodY, has been
shown to regulate expression of many genes in Bacillus
subtilis and Clostridium difficile [49,50]. It appears to
repress genes whose products are not needed during
growth in high nutrient medium. qRT-PCR showed that
CodY was upregulated (6.9 times) in NCTRR and
downregulated (−1.89 times) in 13124R. The sequence
of codY was identical in both ATCC 13124 and 13124R.
Since both mutants and wild types were grown in a
rich medium, the effect of CodY on alteration of gene
expression in our strains is not known.
In addition, microarray analysis also detected some
regulatory genes that were downregulated in both mu-
tants (Table 3) and some that were upregulated in
NCTRR and downregulated in 13124R (Table 1). Among
those genes that were affected differently was CPF_0069,
which is a transcription antiterminator similar to the
BglG-type regulators in other bacteria (http://www.ncbi.
nlm.nih.gov/). This gene was downregulated in 13124R
and upregulated in NCTRR. At this point, the roles that
this gene and others play in altering the transcription of
toxin genes in resistant strains are not known. Nor is
there a reason known for the contradictory effects of
fluoroquinolone resistance selection on the expression
of regulatory genes, including those that regulate toxin
production, and it needs to be investigated further.
Autoinducers (AI-2) also have been implicated in the
regulation of some toxin genes [51]. However, in our
strains, the production of AI-2 per cell unit, measured
by the indicator Vibrio harveyi, was higher for 13124R
than for ATCC 13124 and lower for NCTRR than for
NCTR. The ratio of AI-2 production per OD unit in an
overnight culture of the mutant to that of the wild type
was 1.5 for ATCC 13124 and 0.14 for NCTR. The
contradictory results observed in the transcription of
various toxin genes in two resistant strains were ac-
companied by changes in the levels of toxins and other
enzymes. The most dramatic changes were observed
for phospholipase C (PLC) and perfringolysin O (PFO).
These two toxins were substantially decreased in
13124R and increased in NCTRR. The alterations in the
production of enzymes were accompanied by changes
in cytotoxicity for macrophages. The cytotoxicities of
cell-free culture supernatants of the wild type ATCC
13124 and NCTR, for the macrophages were comparable.
However, the cell-free culture supernatant of 13124R exhi-
bited significantly lower cytotoxicity for macrophages thanATCC 13124, but that of NCTRR had higher cytotoxicity
than NCTR. These data were consistent with the alter-
ations in the transcription patterns of toxin genes and
enzyme assays that were observed by DNA microarray
analysis, qRT-PCR assay and toxin production. The
cytotoxic effects were correlated with the transcription
pattern of toxins and virulence-associated genes and
enzymatic activities, confirming that the effect of fluoro-
quinolones on C. perfringens was strain-specific. O’Brien
and Melville [33] reported that perfringolysin O (PFO)
plays a more prominent role than α-toxin (PLC) in cytotox-
icity for macrophages. Since we used the crude extract,
which contains various factors including PFO and PLC, our
results only show the alteration in the overall cytotoxicities
of the mutants in comparison with their wild types and the
contributing factors and their affinities for macrophage re-
ceptors are not known. Fluoroquinolone resistance selec-
tion decreased the toxicity of 13124R and increased the
toxicity of NCTRR.
Conclusions
Our study demonstrates that gatifloxacin resistance selec-
tion in C. perfringens was associated with upregulation or
downregulation of different genes involved in various as-
pects of metabolism and that the effect was strain-specific.
The genes involved in transcription regulation, virulence
and cell toxicity were among those that were upregulated
in one resistant strain and downregulated in another.
Hiscox et al. [47] surmised that “the regulation of viru-
lence in C. perfringens was a complex process” and we
found that the nature of each strain adds yet another
level of complexity to gene regulation in C. perfringens.
Myer et al. [52] found widely variable large genomic
islands in a large collection of C. perfringens strains and
stated that considerable variation exists among the
genomes of C. perfringens strains. It appears that this
variation in gene structure of different C. perfringens
strains also affects gene regulation and interaction of
bacteria with fluoroquinolones. Fluoroquinolones have
been implied to have a role in the development of C.
difficile associated diarrhea [53]. Since virulent, drug-
resistant clinical isolates of pathogenic bacteria have an un-
defined genetic basis for their resistance and virulence, we
used two wild types and otherwise isogenic resistant mu-
tants, which are difficult to obtain in a clinical setting, to
assess fluoroquinolone effects. Our results reflect clinical
observations of finding fluoroquinolone-resistant strains of
bacteria that are more or less virulent than the susceptible
strains. They underscore the role of fluoroquinolones in
changing bacterial virulence and the importance of prudent
use of fluoroquinolones. Further study is needed on the
effect of fluoroquinolones on a larger number of C.
perfringens strains, along with genomic analysis of the re-
sistant mutants.
Park et al. BMC Microbiology 2013, 13:50 Page 12 of 13
http://www.biomedcentral.com/1471-2180/13/50Additional files
Additional file 1: Primers used for qRT-PCR.
Additional file 2: Analysis of mRNA quality and expression.
Additional file 3: Cytotoxicities of C. perfringens supernatants for
macrophages.
Additional file 4: Morphological examination of C. perfringens strains.
Abbreviations
PLC: Phospholipase C; PFO: Perfringolysin O; gyrA and gyrB: Gyrase; parC and
parE: Topoisomerase IV; BHI: Brain Heart Infusion; VirS, VirR, virX, vrr(VR-RNA),
Cody RevR: Regulatory genes.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Technical experiments and statistical analysis were performed by MP and SP.
SP performed those on RT-PCR and cytotoxicity, morphological analysis and
MP performed the rest of the experiments. SP wrote the first draft of the
manuscript sections on RT-PCR analysis, cytotoxicity and cell morphology. FR
planned the experiments, analyzed the data, and wrote the manuscript. All
authors have read and approved the final manuscript.
Acknowledgments
We thank Drs. Mark Hart and John B. Sutherland for their helpful comments
on the manuscript, Dr. Carl E. Cerniglia for support of research and Drs.
Donald Schwartz and Jean-Marie Rouillard for DNA microarray experiments.
S.P. was supported by the FDA Commissioner’s Fellowship Program. The
views presented in this article do not necessarily reflect those of the US
Food and Drug Administration.
Author details
1Division of Microbiology, National Center for Toxicological Research, US
Food and Drug Administration, Jefferson, AR, USA. 2Current Address; WO66
RM2467, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002, USA.
Received: 31 August 2012 Accepted: 18 February 2013
Published: 1 March 2013
References
1. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al:
Foodborne illness acquired in the United States—major pathogens.
Emerg Infect Dis 2011, 17:7–15.
2. Heimesaat MM, Granzow K, Leidinger H, Liesenfeld O: Prevalence of
Clostridium difficile toxins A and B and Clostridium perfringens
enterotoxin A in stool samples of patients with antibiotic-associated
diarrhea. Infection 2005, 33:340–344.
3. Meyns E, Vermeersch N, Ilsen B, Hoste W, Delooz H, Hubloue I:
Spontaneous intrahepatic gas gangrene and fatal septic shock. Acta Chir
Belg 2009, 109:400–404.
4. Rood JI: Virulence genes of Clostridium perfringens. Annu Rev Microbiol
1998, 52:333–360.
5. Sparks SG, Carman RJ, Sarker MR, McClane BA: Genotyping of
enterotoxigenic Clostridium perfringens fecal isolates associated with
antibiotic-associated diarrhea and food poisoning in North America.
J Clin Microbiol 2001, 39:883–888.
6. Petit L, Gibert M, Popoff MR: Clostridium perfringens: toxinotype and
genotype. Trends Microbiol 1997, 179:104–110.
7. Titball RW, Hunter SE, Martin KL, Morris BC, Shuttleworth AD, Rubidge T, et al:
Molecular cloning and nucleotide sequence of the alpha-toxin
(phospholipase C) of Clostridium perfringens. Infect Immun 1989, 57:367–376.
8. Lazarescu C, Kimmoun A, Blatt A, Bastien C, Levy B: Clostridium perfringens
gangrenous cystitis with septic shock and bone marrow necrosis.
Intensive Care Med 2012, 38:1906–1907.
9. Gosselink MP, Schouten WR, van Lieshout LM, Hop WC, Laman JD, et al:
Eradication of pathogenic bacteria and restoration of normal pouchflora: comparison of metronidazole and ciprofloxacin in the treatment of
pouchitis. Dis Colon Rectum 2004, 47:1519–1525.
10. Gionchetti P, Rizzello F, Venturi A, Ugolini F, Rossi M, Brigidi P, et al:
Antibiotic combination therapy in patients with chronic, treatment-
resistant pouchitis. Aliment Pharmacol Ther 1999, 13:713–718.
11. Leal J, Gregson DB, Ross T, Church DL, Laupland KB: Epidemiology of
Clostridium species bacteremia in Calgary, Canada, 2000–2006. J Infect
2008, 5:198–203.
12. Wexler HM, Molitoris E, Finegold SM: In vitro activities of three of the
newer quinolones against anaerobic bacteria. Antimicrob Agents
Chemother 1992, 36:239–234.
13. Ferrero L, Cameron B, Crouzet J: Analysis of gyrA and grlA mutations in
stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus
aureus. Antimicrob Agents Chemother 1995, 39:1554–1558.
14. Tamayo M, Santiso R, Gosalvez J, Bou G, Fernandez JL: Rapid assessment of
the effect of ciprofloxacin on chromosomal DNA from Escherichia coli
using an in situ DNA fragmentation assay. BMC Microbiol 2009, 9:69.
15. Cirz RT, Jones MB, Gingles NA, Minogue TD, Jarrahi B, Peterson SN, et al:
Complete and SOS-mediated response of Staphylococcus aureus to the
antibiotic ciprofloxacin. J Bacteriol 2007, 189:531–539.
16. Dorr T, Lewis K, Vulic M: SOS response induces persistence to
fluoroquinolones in Escherichia coli. PLoS Genet 2009, 5:e1000760.
17. Dorr T, Vulic M, Lewis K: Ciprofloxacin causes persister formation by
inducing the TisB toxin in Escherichia coli. PLoS Biol 2010, 8:e1000317.
18. Dal Sasso M, Culici M, Bovio C, Braga PC: Gemifloxacin: effects of sub-
inhibitory concentrations on various factors affecting bacterial virulence.
Int J Antimicrob Agents 2003, 21:325–333.
19. Dorman CJ, Ni Bhriain N, Higgins CF: DNA supercoiling and environmental
regulation of virulence gene expression in Shigella flexneri. Nature 1990,
344:789–792.
20. Mesak LR, Davies J: Phenotypic changes in ciprofloxacin-resistant
Staphylococcus aureus. Res Microbiol 2009, 160:785–791.
21. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, et al: A
large outbreak of Clostridium difficile-associated disease with an
unexpected proportion of deaths and colectomies at a teaching hospital
following increased fluoroquinolone use. Infect Control Hosp Epidemiol
2005, 26:273–280.
22. Noren T: Clostridium difficile and the disease it causes. Methods Mol Biol
2010, 646:9–35.
23. Pawlowski SW, Archbald-Pannone L, Carman RJ, Alcantara-Warren C, Lyerly
D, Genheimer CW, et al: Elevated levels of intestinal inflammation in
Clostridium difficile infection associated with fluoroquinolone-resistant C.
difficile. J Hosp Infect 2009, 73:185–187.
24. Saxton K, Baines SD, Freeman J, O'Connor R, Wilcox MH: Effects of
exposure of Clostridium difficile PCR ribotypes 027 and 001 to
fluoroquinolones in a human gut model. Antimicrob Agents Chemother
2009, 53:412–420.
25. Uchida Y, Mochimaru T, Morokuma Y, Kiyosuke M, Fujise M, Eto F, et al:
Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli
serogroup O25 strains, and associated virulence factors. Int J Antimicrob
Agents 2010, 35:444–450.
26. Drews SJ, Poutanen SM, Mazzulli T, McGeer AJ, Sarabia A, Pong-Porter S,
et al: Decreased prevalence of virulence factors among ciprofloxacin-
resistant uropathogenic Escherichia coli isolates. J Clin Microbiol 2005,
43:4218–4220.
27. Ferjani S, Saidani M, Ennigrou S, Hsairi M, Ben Redjeb S: Virulence
determinants, phylogenetic groups and fluoroquinolone resistance in
Escherichia coli isolated from cystitis and pyelonephritis. Pathol Biol (Paris)
2012, 60:270–274.
28. Sun J, Hu J, Peng H, Shi J, Dong Z: Molecular and physiological
characterization of fluoroquinolone resistance in relation to
uropathogenicity among Escherichia coli isolates isolated from Wenyu
River, China. Chemosphere 2012, 87:37–42.
29. Rafii F, Park M, Novak JS: Alterations in DNA gyrase and topoisomerase IV in
resistant mutants of Clostridium perfringens found after in vitro treatment
with fluoroquinolones. Antimicrob Agents Chemother 2005, 49:488–492.
30. Rafii F, Park M, Bryant AE, Johnson SJ, Wagner RD: Enhanced production of
phospholipase C and perfringolysin O (alpha and theta toxins) in a
gatifloxacin-resistant strain of Clostridium perfringens. Antimicrob Agents
Chemother 2008, 52:895–900.
Park et al. BMC Microbiology 2013, 13:50 Page 13 of 13
http://www.biomedcentral.com/1471-2180/13/5031. Rafii F, Park M, Gamboa da Costa G, Camacho L: Comparison of the
metabolic activities of four wild-type Clostridium perfringens strains with
their gatifloxacin-selected resistant mutants. Arch Microbiol 2009,
191:895–902.
32. Ohtani K, Hirakawa H, Tashiro K, Yoshizawa S, Kuhara S, Shimizu T:
Identification of a two-component VirR/VirS regulon in Clostridium
perfringens. Anaerobe 2010, 16:258–264.
33. O'Brien DK, Melville SB: Effects of Clostridium perfringens alpha-toxin (PLC)
and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape
from the phagosomes of macrophages, and on persistence of C.
perfringens in host tissues. Infect Immun 2004, 72:5204–5215.
34. Awad MM, Ellemor DM, Bryant AE, Matsushita O, Boyd RL, Stevens DL, et al:
Construction and virulence testing of a collagenase mutant of
Clostridium perfringens. Microb Pathog 2000, 28:107–117.
35. Dargatz H, Diefenthal T, Witte V, Reipen G, von Wettstein D: The
heterodimeric protease clostripain from Clostridium histolyticum is
encoded by a single gene. Mol Gen Genet 1993, 240:140–145.
36. Li J, Sayeed S, Robertson S, Chen J, McClane BA: Sialidases affect the host
cell adherence and epsilon toxin-induced cytotoxicity of Clostridium
perfringens type D strain CN3718. PLoS Pathog 2011, 7:e1002429.
37. Song JM, Im JH, Hoon JH, Kang JD, Kang DJ: A simple method for hyaluronic
acid quantification in culture broth. Carbohydr Polym 2009, 78:633–634.
38. Kugelberg E, Lofmark S, Wretlind B, Andersson DI: Reduction of the fitness
burden of quinolone resistance in Pseudomonas aeruginosa. J Antimicrob
Chemother 2005, 55:22–30.
39. Marcusson LL, Frimodt-Moller N, Hughes D: Interplay in the selection of
fluoroquinolone resistance and bacterial fitness. PLoS Pathog 2009, 5:e1000541.
40. Bachoual R, Tankovic J, Soussy CJ: Analysis of the mutations involved in
fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia
coli. Microb Drug Resist 1998, 4:271–276.
41. Smani Y, Lopez-Rojas R, Dominguez-Herrera J, Docobo-Perez F, Marti S, Vila
J, et al: In vitro and in vivo reduced fitness and virulence in ciprofloxacin-
resistant Acinetobacter baumannii. Clin Microbiol Infect 2012, 18:1–4.
42. Shimizu T, Shima K, Yoshino K, Yonezawa K, Hayashi H: Proteome and
transcriptome analysis of the virulence genes regulated by the VirR/VirS
system in Clostridium perfringens. J Bacteriol 2002, 184:2587–2594.
43. Shimizu T, Yaguchi H, Ohtani K, Banu S, Hayashi H: Clostridial VirR/VirS
regulon involves a regulatory RNA molecule for expression of toxins.
Mol Microbiol 2002, 43:257–265.
44. Okumura K, Ohtani K, Hayashi H, Shimizu T: Characterization of genes
regulated directly by the VirR/VirS system in Clostridium perfringens.
J Bacteriol 2008, 190:7719–7727.
45. Obana N, Shirahama Y, Abe K, Nakamura K: Stabilization of Clostridium
perfringens collagenase mRNA by VR-RNA-dependent cleavage in 5'
leader sequence. Mol Microbiol 2010, 77:1416–1428.
46. Ohtani K, Bhowmik SK, Hayashi H, Shimizu T: Identification of a novel locus
that regulates expression of toxin genes in Clostridium perfringens. FEMS
Microbiol Lett 2002, 209:113–118.
47. Hiscox TJ, Chakravorty A, Choo JM, Ohtani K, Shimizu T, Cheung JK, et al:
Regulation of virulence by the RevR response regulator in Clostridium
perfringens. Infect Immun 2011, 79:2145–2153.
48. Obana N, Nakamura K: A novel toxin regulator, the CPE1446-CPE1447
protein heteromeric complex, controls toxin genes in Clostridium
perfringens. J Bacteriol 2011, 193:4417–4424.
49. Brinsmade SR, Sonenshein AL: Dissecting complex metabolic integration
provides direct genetic evidence for CodY activation by guanine
nucleotides. J Bacteriol 2011, 193:5637–5648.
50. Dineen SS, McBride SM, Sonenshein AL: Integration of metabolism and
virulence by Clostridium difficile CodY. J Bacteriol 2010, 192:5350–5362.
51. Ohtani K, Yuan Y, Hassan S, Wang R, Wang Y, Shimizu T: Virulence gene
regulation by the agr system in Clostridium perfringens. J Bacteriol 2009,
191:3919–3927.
52. Myers GS, Rasko DA, Cheung JK, Ravel J, Seshadri R, DeBoy RT, et al:
Skewed genomic variability in strains of the toxigenic bacterial
pathogen, Clostridium perfringens. Genome Res 2006, 16:1031–1040.53. Deshpande A, Pant C, Jain A, Fraser TG, Rolston DD: Do fluoroquinolones
predispose patients to Clostridium difficile associated disease? A review
of the evidence. Curr Med Res Opin 2008, 24:329–333.
doi:10.1186/1471-2180-13-50
Cite this article as: Park et al.: Comparative transcription analysis and
toxin production of two fluoroquinolone-resistant mutants of
Clostridium perfringens. BMC Microbiology 2013 13:50.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
